logo
I went on my first diet age 10. Now I'm on Mounjaro and won't look back

I went on my first diet age 10. Now I'm on Mounjaro and won't look back

Yahoo6 hours ago
I was just 10 years old when I went on my first diet. I remember so vividly being little and first becoming aware of my body, that it was different from everyone else's, or that I was built differently to my friends. My mum and I would even have contests to see who could lose the most weight. Ever since then I struggled endlessly with my weight – until I came to the decision stay on the weight-loss drug Mounjaro for the rest of my life.
The truth is, I've tried everything – Weight Watchers, SlimFast, the Atkins Diet. I even tried cutting out refined foods and dairy, and drinking solely shakes. I hired a personal chef, and a personal trainer too. Nothing stuck. Then I went on Mounjaro and lost 2st in three months, and 6st within a year. Now that I've reached 10st, my focus is on maintaining it. That is why I am still on the medication and will probably be on it forever. I have to keep the obesity at bay, and Mounjaro treats my disease and keeps me healthy.
I know a lot of people will have their opinions of me and my choices – I've heard it all. I'm ok with what they say because amongst all the hate, maybe I've reached someone who might be afraid of trying it, and this story changes their life.
My husband Erik and I live with our three children, two daughters aged eight and five, and one son aged 11, in New Jersey. I was a teacher for 10 years but after I had my first child in 2014, I switched jobs to be able to work from home because it was difficult to pay for daycare. After my second child, my husband became a full-time doctor and made enough money so that I was able to become a stay-at-home mum.
For the next eight years, I continued as normal while eating huge food portions. Eventually, it got out of control. I couldn't breathe doing cardio, I couldn't even play with my children. I'm an avid equestrian and I wasn't able to ride or do my lessons any more. We'd just trot around – I felt so bad that I was letting my horse down.
I can't even tell you how many weddings I turned down because I wasn't happy with my weight, or how many social events I missed because I didn't feel pretty enough. I felt I was the only person in the world struggling.
My mum and my grandmother both suffer from obesity as well. Growing up, my mum would say, 'Oh, we don't eat that food', or 'That's bad food, we need to eat good food.' Her words contributed to an unhealthy narrative around food. I always felt bad about eating a cookie or a slice of cake. It wasn't healthy to be having these conversations about my body at such a young age.
During my 20s and 30s, I thought that my health was infallible and that nothing could happen to me. Then in 2022, when I was 16st and just about to turn 40, I got my blood tests back and I discovered I was pre-diabetic and obese. It was such a shock to me: I'd always know I was a bit bigger, but I didn't realise my health was reflecting that.
I was at the end of my tether – something had to change. I read an article in The New York Post about someone else's experience on Mounjaro.When this medication first came out it was still new in treating weight loss. Before Mounjaro, weight-loss drugs had a very bad reputation – they had terrible side effects so you couldn't be on them for too long.
I sat my husband down and told him I'd looked into this new drug and I wanted to explore it. He said he wanted me to do some research into it to make sure it wasn't just a fad, but after a few days he came back to me and said that it was a legitimate medication. We then went about finding a doctor. At the time, only endocrinologists were prescribing the medication because of their work with diabetic patients, and because I was pre-diabetic, I was able to qualify, so we travelled to New York City.
My endocrinologist prescribed me the starting dose, 2.5mg. She prepared me well for the side effects. She said I'd feel nauseous for the first couple of months, I might feel tired, and I wouldn't feel hungry.
I'd describe the side effects to be similar to the first trimester of pregnancy. I know a lot of women on the medication suffer from constipation or diarrhoea but fortunately, I didn't have that. The doctor recommended I work with a nutritionist during the first months. I realised that although I was not hungry, I still had to fuel my body with good food. The nutritionist told me that not eating balanced meals while on the medication could lead to hair loss, skin issues and a vitamin D deficiency.
She told me to take a fibre supplement, drink plenty of water and drink protein shakes or smoothies daily. Three years later, a protein shake is still my go-to life hack – it's like a cheat sheet to ensure you are getting the nutrients in.
When I first started using Mounjaro, I was very quiet about it. My husband was the only person that knew about it for three months. I was nervous about the judgement – what if people told me that I took the easy way out? I lost 30lb (2st) in three months, and slowly friends would start to tell me that I looked good, and I decided to be honest about how I'd done it.
My relationship with food also changed: I had so much emotional baggage and lifelong disappointment that I had to learn to erase. I had to learn that there was no such thing as 'bad food', it was just food. If I wanted to have some chocolate cake, I could have a few bites and have the strength to walk away. On previous diets, if I ate a slice of chocolate cake, I'd spiral and binge-eat the entire cake.
After a few months on 2.5mg, I went up to 5mg for three months. After that I stopped losing weight, so I increased it to 7.5mg. Every time I plateaued and went longer than three weeks without weight loss, I would increase the dose. Once I went up to 12.5mg I reached my target of losing 95lb, which is just over 6st.
The medication has offered me so many other health benefits – the inflammation in my knees and ankles has gone down. Before I lost weight, I was having a lot of trouble on my horse and I went to physical therapy to try and address it, but nothing worked. Once I lost the weight, I suddenly didn't have any pain at all.
My anxiety and depression have also drastically improved. When I weighed 16st, I was unable to leave my house and when I did, it was only to go into town to run errands. If anyone asked me to go for lunch or dinner, the answer was no. If I was invited to a party for the evening, I wouldn't go. After losing 6st, the travel fear went away – me and my husband went on a flight to Paris, and took weekend trips to New York City.
When I started noticing results, I decided to make a TikTok account because at the time, none of my friends were on there, so I could post without them seeing. Eleven months into using Mounjaro, I'd slimmed down to a US size 6 (roughly a UK size 10). I fit into clothes that I couldn't fit into before; going in and being able to fit into medium and small-sized clothes was so exciting. I was able to go out to parties and I became very social.
I gained a newfound confidence which many people start to lose in their 40s but for me, it continues to grow. I've started dabbling in interior design and am even considering opening up my own business. I just know I wouldn't have had the confidence to do that three years ago.
Ironically, I feel like my mum was a bit jealous of my successful weight loss. She realised how hard she had to work and how much she had to restrict herself to stay in shape, whereas I was able to be healthier and thinner without all that hard work. At dinner, I was able to order pasta and a glass of wine, and she had to sit there with her plain chicken. I had a lot more enjoyment in my life and I think she was envious of how many people said I looked good.
After I had lost around 75lb, Erik took me to a shop so I could buy new boots and breeches. It was so exciting to be able to buy equestrian clothes that I wasn't able to fit into before. I love the European equestrian brands like Redpost and Holland Cooper, and now I could shop there – these are the experiences that I hold so dear.
I suffer from chronic depression, and although Mounjaro has helped me manage some of my symptoms, I know I'll be on antidepressants for the rest of my life. I truly believe it's the same with obesity, and so my clinician and I worked to bring me down to a dose that keeps me balanced, so I'm not losing or gaining weight. We initially trialled going from 12.5mg down to 7.5mg, but I started to gain weight again so I went back up to 10mg and have stayed there for almost two years.
I've had such a good experience with the medication that my husband started to take it too. He isn't obese, but once he hit 40, he became more conscious of his dad bod and wanted to feel good about himself. He hasn't lost as much as I did, probably around 30 to 40lb, and I think that is down to the fact he's not clinically obese. We are still figuring things out and discovering new science with this medication – we are the first generation.
Now I look at my eight-year-old daughter, who is a fuller-sized, beautiful girl, and know that's ok. We have healthy conversations about listening to our bellies and eating when we are hungry. I don't want her on Mounjaro, but if she needed to be on it when she's older, I'd understand. Some parts of maintaining her figure are out of her control, and now there's medication to help with that. That's why I look at Mounjaro as the medication that broke my generational curse.
My only issue is with how cost-prohibitive the medication is. In the US, most of the insurance companies don't cover weight-loss drugs, even though obesity is a disease. They believe that everyone can just lose weight with diet and exercise, when that is not the case. I pay $1200 (£880) a month for my medication – that's most people's rent, a lot can't afford it. (In the UK, you can get Mounjaro on an NHS prescription for £9.90, or from a private clinic for around £180 a month.)
I'm so happy that there's finally an answer to obesity. At 41, the unhealthy food narratives that have always been a battle, I've finally been able to put to an end.
As told to Nicole Collins
Breakfast: Coffee, three eggs, two pieces of toast
Snack: Handfuls of cereal, children's snacks
Lunch: A foot-long Subway sandwich with crisps, a cookie and a soda
More snacking
Dinner: Large portion of chicken and pasta
Dessert: Coco puffs
Alcohol: Two glasses of wine at night
Exercise: Horse riding – even though it was very difficult
Breakfast: High-fibre cereal like raisin bran
Snack: Protein shake
Lunch: Soup and Vietnamese spring roll
Dinner: Light dinner like a mince salad with taco shells
Dessert: No dessert
Alcohol: Mounjaro changed my relationship with alcohol, so I don't drink any more unless I'm out in a social setting, and I often feel nauseous when I do
Exercise: Horse riding, I'm now able to ride properly every day
By Dr Kaywaan Khan, a GP and weight-loss and wellbeing specialist at Hannah London, and Dr Leah Totton, a medical and cosmetic doctor at Dr Leah Clinics and Skincare
Yes, you can use Mounjaro in the long term, says Dr Khan. Some people 'will take the medication forever because they not only have obesity as a chronic disease, but they [have conditions such as] heart disease or diabetes so taking this medication is part of their core health treatment and preventative health care,' Dr Khan adds.
'A woman who is already overweight might already be having irregular periods, so Mounjaro might actually help those women to regulate their periods,' says Dr Khan. 'It can potentially stop periods if you have too little fat. Alternatively you might have enough fat but if you lose weight too quickly, it can put the body into shock because of a very little calorie intake.'
'Slow weight loss is advised. I would recommend reducing the speed in which you lose weight and increasing your protein intake during the weight loss process,' says Dr Totton. 'I would also suggest doing resistance training to work on the lean muscle mass. You can also take collagen peptides and vitamin C to support skin health, or consider treatments such as radio frequency or microneedling to stimulate collagen elastin and tighten the skin.'
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years
Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years

Yahoo

timean hour ago

  • Yahoo

Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years

It is doubtless a positive to see that the OptimizeRx Corporation (NASDAQ:OPRX) share price has gained some 73% in the last three months. But that is small recompense for the exasperating returns over three years. Indeed, the share price is down a tragic 55% in the last three years. Some might say the recent bounce is to be expected after such a bad drop. While many would remain nervous, there could be further gains if the business can put its best foot forward. It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Because OptimizeRx made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size. Over three years, OptimizeRx grew revenue at 16% per year. That's a fairly respectable growth rate. So some shareholders would be frustrated with the compound loss of 16% per year. The market must have had really high expectations to be disappointed with this progress. So this is one stock that might be worth investigating further, or even adding to your watchlist. The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail). We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. So we recommend checking out this free report showing consensus forecasts It's good to see that OptimizeRx has rewarded shareholders with a total shareholder return of 34% in the last twelve months. Notably the five-year annualised TSR loss of 1.3% per year compares very unfavourably with the recent share price performance. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - OptimizeRx has 1 warning sign we think you should be aware of. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

The heat has a surprising effect on the brain — here's what doctors want you to know
The heat has a surprising effect on the brain — here's what doctors want you to know

Fox News

timean hour ago

  • Fox News

The heat has a surprising effect on the brain — here's what doctors want you to know

Summer heat has swept the U.S., with warnings issued across the East Coast and Midwest. In addition to putting stress on the body, hot weather can also take a toll on the brain and mental health. Dr. Jace Reed, director of emergency psychiatry at Cedars-Sinai Hospital in Los Angeles, emphasized in an interview with Fox News Digital that the brain is a major organ that can be greatly affected by heat. Extreme heat can cause mental health changes like increased irritability and anxiety, along with decreased memory, attention and reaction time. This can affect daily interactions socially and professionally, the expert cautioned. "You may be slower at completing your task or remembering what someone just told you," he told Fox News Digital. "Those can be initial early signs that the heat is affecting your brain and your mental abilities." Symptoms like extreme confusion could mark the beginning of a heat stroke, which could require hospitalization, the psychiatrist warned. In a separate interview with Fox News Digital, Thea Gallagher, a doctor of psychology and director of wellness programs at NYU Langone Health, noted that when the body overheats, it struggles to regulate internal balance. This can lead to disrupted sleep, fatigue and poor concentration, as well as impaired cognitive function, slow reaction times and struggles with decision-making. The heat can also increase oxidative stress and inflammation in the brain, Gallagher added, which can potentially damage neurons, worsen existing neurological conditions and raise stroke risk. "Heat exposure may trigger an inflammatory response in the brain," she said. "In cases like heatstroke, inflammation is believed to contribute to symptoms such as confusion and delirium." Excessive heat can also weaken the protective blood-brain barrier, according to the expert, which makes the brain more vulnerable to toxins and pathogens. Higher temperatures are also associated with disturbances in mood and violent behavior, especially during prolonged heatwaves. Psychiatric emergency visits for anxiety, depression and substance use also rise significantly on the hottest days, Gallagher confirmed. Below are some of the main mental symptoms that can worsen in hot weather, experts cautioned. People who suffer from mental health conditions such as mood disorders, schizophrenia, anxiety or even dementia are more vulnerable in hot weather. Some psychiatric medications could make it difficult for the body to regulate temperature or stay hydrated, Gallagher noted, while heat can "intensify" symptoms like agitation or paranoia. "People with cognitive impairments may not recognize the signs of overheating," she added. "Some SSRIs (selective serotonin reuptake inhibitors) can suppress sweat production, which is the body's primary cooling mechanism. This raises the risk of overheating, dehydration and even heat stroke." "Paradoxically, SSRIs can also cause excessive sweating in some individuals — a side effect known as 'SSRI sweats,'" she went on. "While this might seem like it would help with cooling, it can actually lead to dehydration if fluid intake doesn't keep up." The experts recommended the following practices to protect brain health in extreme heat. For more Health articles, visit "Days are also longer and there are more activities, which can be exhausting," Gallagher noted. "Therefore, it is good to prioritize sleep and rest … and [find] ways to slow down when you can."

What to Expect From Universal Health Services' Next Quarterly Earnings Report
What to Expect From Universal Health Services' Next Quarterly Earnings Report

Yahoo

timean hour ago

  • Yahoo

What to Expect From Universal Health Services' Next Quarterly Earnings Report

King of Prussia, Pennsylvania-based Universal Health Services, Inc. (UHS) owns and operates acute care hospitals, and outpatient and behavioral health care facilities. Valued at a market cap of $12 billion, the company's range of services include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and behavioral health services. It is expected to announce its fiscal Q2 earnings for 2025 on Wednesday, Jul. 23. Prior to this event, analysts project this healthcare company to report a profit of $4.87 per share, up 13% from $4.31 per share in the year-ago quarter. The company has exceeded Wall Street's bottom-line estimates in three of the last four quarters, while missing on another occasion. Its earnings of $4.84 per share in the previous quarter outpaced the consensus estimates by 11%. Is UnitedHealth Stock a Buy, Sell, or Hold for July 2025? Michael Saylor Says 'You'll Wish You'd Bought More' Bitcoin as MicroStrategy Doubles Down Is Microsoft Stock About to Go Nuclear? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! For the full year, analysts expect UHS to report EPS of $19.43, up 17% from $16.61 in fiscal 2024. Furthermore, its EPS is expected to grow 8.9% year-over-year to $21.16 in fiscal 2026. UHS has declined marginally over the past 52 weeks, lagging behind the S&P 500 Index's ($SPX) 13% return over the same time frame. However, it has outpaced the Health Care Select Sector SPDR Fund's (XLV) 6.3% downtick over the same time period. On Apr. 28, UHS released its Q1 results, and its shares closed down marginally in the following trading session. The company's overall revenue improved 6.7% year-over-year to $4.1 billion but fell short of the consensus estimates by nearly 1%. Meanwhile, on the earnings front, due to favorable pricing and margin improvement, the company's adjusted EPS surged 30.8% year-over-year to $4.84 and surpassed the analyst estimates by 11%. Wall Street analysts are moderately optimistic about UHS' stock, with a "Moderate Buy" rating overall. Among 19 analysts covering the stock, eight recommend "Strong Buy," and 11 advise 'Hold.' The mean price target for UHS is $226.19, which indicates a 22.6% potential upside from the current levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store